Tau and α-synuclein inclusions in a case of familial frontotemporal dementia and progressive aphasia

Journal of Neuropathology and Experimental Neurology

Volumn 64, Issue 3, 2005, Pages 245-253

  Yancopoulou, Despina ^a   Xuereb, John H ^a   Crowther, R Anthony ^b   Hodges, John R ^a   Spillantini, Maria Grazia ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Frontotemporal dementia; Lewy bodies; Neurodegenerative diseases; Neurofibrillary tangles; Progressive aphasia; Tau protein; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; PARKIN; TAU PROTEIN;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; BASAL GANGLION; CASE REPORT; CELL INCLUSION; DNA SEQUENCE; ELECTRON MICROSCOPY; FAMILIAL DISEASE; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; MEYNERT BASAL NUCLEUS; NEURITE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NUCLEOTIDE REPEAT; POLYMERASE CHAIN REACTION; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; WESTERN BLOTTING;

EID: 15244354724     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/64.3.245     Document Type: Article

References (44)

1. Spillantini MG, Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci 1998;21:428-33
2. Yancopoulou D, Spillantini MG. Tau protein in familial and sporadic diseases. Neuromolecular Med 2003;4:37-48
3. Spillantini MG, Schmidt ML, Lee VMY, et al. α-Synuclein in Lewy bodies. Nature 1997;388:839-40
4. Spillantini MG, Crowther RA, Jakes R, et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 1998;95:6469-73
5. Spillantini MG, Crowther RA, Jakes R, et al. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998;251:205-8
6. Hamilton RL. Lewy bodies in Alzheimer's disease: A neuropathologic review of 145 cases using α-synuclein immunohistochemistry. Brain Pathol 2000;10:378-84
7. Lippa CF, Fujiwara H, Mann DM, et al. Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998;153:1365-70
8. Lippa CF, Schmidt ML, Lee VM-Y, et al. Antibodies to α-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. Ann Neurol 1999;45:353-57
9. Judkins AR, Forman MS, Uryu K, et al. Co-occurrence of Parkinson's disease with progressive supranuclear palsy. Acta Neuropathol 2002;103:526-30
10. Mori H, Oda M, Komori T, et al. Lewy bodies in progressive supranuclear palsy. Acta Neuropathol 2002;104:273-78
11. Wakabayashi K, Fukushima T, Koide R, et al. Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and Lewy body pathology. Acta Neuropathol 2000;99:331-36
12. Forman MS, Schmidt ML, Kasturi S, et al. Tau and α-synuclein pathology in amygdala of parkinsonism-dementia complex patients of Guam. Am J Pathol 2002;160:1725-31
13. Wilhelmsen KC, Forman MS, Rosen HJ, et al. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Arch Neurol 2004;61:398-406
14. Duda JE, Giasson BT, Mabon ME, et al. Concurrence of α-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol 2002;104:7-11
15. Ishizawa T, Mattila P, Davies P, et al. Colocalisation of tau and alpha-synuclein epitopes in Lewy bodies. J Neuropathol Exp Neurol 2003;62:389-97
16. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology 1998;51:1546-54
17. McKhann GM, Albert MS, Grossman M, et al. Clinical and pathologic diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803-9
18. Hodges JR, Davies RR, Xuereb JH, et al. Clinicopathologic correlates in frontotemporal dementia. Ann Neurol 2004;56:399-406
19. Neary D, Snowden JS, Mann DM. Familial progressive aphasia: Its relationship to other forms of lobar atrophy. J Neurol Neurosurg Psychiatry 1993;56:1122-25
20. Ghetti B, Murrell JR, Zolo P, et al. Progress in hereditary tauopathies: A mutation in the Tau gene (G389R) causes a Pick disease-like syndrome. Ann NY Acad Sci 2000;920:52-62
21. Shafiq M, Nee L, Grafman J, et al. Frontotemporal dementia: Report of a familial case. Neurology 2001;56(suppl):31-34
22. Krefft TA, Graff-Radford NR, Dickson DW, et al. Familial primary progressive aphasia. Alzheimer Dis Assoc Disord 2003;17:106-12
23. Croot K, Patterson K, Hodges JR. Familial progressive aphasia: Insights into the nature and deterioration of single word processing. Cogn Neuropsychol 1999;16:705-47
24. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86
25. Spillantini MG, Murrell JR, Goedert M, et al. Mutation in the tau gene in familial multiple system tauopthy with presenile dementia. Proc Natl Acad Sci USA 1998;95:7737-41
26. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998;392:605-8
27. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-47
28. Goedert M, Jakes R. Expression of separate isoforms of human tau protein: Correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J 1990;9:4225-30
29. Goedert M, Spillantini MG, Cairns NJ, et al. Tau proteins of Alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms. Neuron 1992;8:159-68
30. Crowther RA. Straight and paired helical filaments in Alzheimer's disease have a common structural unit. Proc Nat Acad Sci USA 1992;88:2288-92
31. Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999;8:711-15
32. Sanchez MP, Gonzalo I, Avila J, et al. Progressive supranuclear palsy and tau hyperphosphorylation in a patient with a C212Y parkin mutation. J Alzheimers Dis 2002;4:399-404
33. Shimura H, Schlossmacher MG, Hattori N, et al. Ubiquitination of a new form of α-synuclein by parkin from human brain: Implications for Parkinson's disease. Science 2001;293:263-69
34. Farrer M, Chan P, Chen R, et al. Lewy bodies and parkinsonism in families with Parkin mutations. Ann Neurol 2001;50:293-300
35. Hashimoto M, Rockenstein E, Mante M, et al. Beta-synuclein inhibits α-synuclein aggregation: A possible link as an anti-parkinsonian factor. Neuron 2001;32:213-23
36. van Herpen E, Rosso SM, Serverijnen LA, et al. Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R. Ann Neurol 2003;54:573-81
37. Pastor P, Pastor E, Carnero C, et al. Familial atypical progressive supranuclear palsy associated with homozygosity for the delN296 mutation in the tau gene. Ann Neurol 2001;49:263-67
38. Nicholl DJ, Greenstone MA, Clarke CE, et al. An English kindred with a novel recessive tauopathy and respiratory failure. Ann Neurol 2003;54:682-86
39. Probst A, Tolnay M, Langui D, et al. Pick's disease: Hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta Neuropathol 1996;92:588-96
40. Rizzini C, Goedert M, Hodges JR, et al. Tau gene mutation K257T causes a tauopathy similar to Pick's disease. J Neuropathol Exp Neurol 2000;59:990-1001
41. Neumann M, Schulz-Schaeffer W, Crowther RA, et al. Pick's disease associated with the novel tau gene mutation K369I. Ann Neurol 2001;50:503-13
42. Giasson B, Forman MS, Higuchi M, et al. Initiation and synergistic fibrillization of tau and α-synuclein. Science 2003;300:636-40
43. Borroni B, Yancopoulou D, Tsutsui M, et al. Association between tau H2 haplotype and age of onset in frontotemporal dementia. Arch Neurol 2005, in press
44. Kwok JB, Teber ET, Loy C, et al. Tau haplotypes regulate transcription and are associated with Parkinson's disease. Ann Neurol 2004;55:329-34